Skip to main content

Galectin Therapeutics Inc. - Common Stock (NQ: GALT )

1.040 -0.960 (-48.00%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
November 08, 2012
Form 8-K
Source: SEC/Edgar
October 03, 2012
Form 8-K
Source: SEC/Edgar
September 20, 2012
Form 8-K
Source: SEC/Edgar
August 28, 2012
Form 8-K
Source: SEC/Edgar
August 09, 2012
Form 8-K
Source: SEC/Edgar
July 24, 2012
Form 8-K
Source: SEC/Edgar
May 29, 2012
Form 8-K
Source: SEC/Edgar
May 10, 2012
Form 8-K
Source: SEC/Edgar
May 02, 2012
Form 8-K
Source: SEC/Edgar
April 30, 2012
Form DEF 14A
Source: SEC/Edgar
April 19, 2012
Form 8-K
Source: SEC/Edgar
April 10, 2012
Form 8-K
Source: SEC/Edgar
March 29, 2012
Form 8-K
Source: SEC/Edgar
March 25, 2012
Form 424B2
Source: SEC/Edgar
March 22, 2012
Form 8-K
Source: SEC/Edgar
March 22, 2012
Form 8-A12B/A
Source: SEC/Edgar
March 21, 2012
Form CERTNAS
Source: SEC/Edgar
March 21, 2012
Form 424B5
Source: SEC/Edgar
March 05, 2012
Form 8-K
Source: SEC/Edgar
March 04, 2012
Form 8-K
Source: SEC/Edgar
February 26, 2012
Form 8-K
Source: SEC/Edgar
February 13, 2012
Form EFFECT
Source: SEC/Edgar
January 26, 2012
Form POS AM
Source: SEC/Edgar
January 19, 2012
Form 8-K
Source: SEC/Edgar
January 08, 2012
Form CT ORDER
Source: SEC/Edgar
January 03, 2012
Form 8-K
Source: SEC/Edgar
December 19, 2011
Form 8-K
Source: SEC/Edgar
December 18, 2011
Form 8-K
Source: SEC/Edgar
November 21, 2011
Form POS AM
Source: SEC/Edgar
November 14, 2011
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.